Get the Stockscreener App
5.58
6.75%
0.37
Avita Medical Inc stock is traded at $5.58, with a volume of 115.75K.
It is up +6.75% in the last 24 hours and up +7.57% over the past month.
Avita is a single product company. Its RECELL system is an innovative burn treatment device which creates Spray-on Skin from a small skin sample within 30 minutes, thus avoiding or reducing the need for skin grafts. It's approved for the treatment of adult and paediatric patients in the US and an expanded indication for soft-tissue reconstruction. It is currently in roll-out across the approximately 136 US burn centers. Despite having product approval in Australia, Europe, Canada, and China, Avita is not actively marketing in those territories and focussing instead on the US region. However, it is expected to launch in Japan via distribution partner Cosmotec in second-half fiscal 2022. Avita is domiciled, and has its primary listing, in the US.
See More
Previous Close:
$5.21
Open:
$5.35
24h Volume:
115.75K
Relative Volume:
0.40
Market Cap:
$147.24M
Revenue:
$50.14M
Net Income/Loss:
$-35.38M
P/E Ratio:
-3.9857
EPS:
-1.4
Net Cash Flow:
$-39.46M
1W Performance:
+3.95%
1M Performance:
+7.57%
6M Performance:
-34.42%
1Y Performance:
-43.88%
1-Day Range:
$5.325
$5.57
1-Week Range:
$5.0327
$5.85
52-Week Range:
$4.71
$14.16
Avita Medical Inc Stock (RCEL) Company Profile
Name
Avita Medical Inc
Sector
Industry
Phone
661-568-1317
Address
28159 AVENUE STANFORD, VALENCIA, CA
Compare RCEL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RCEL
Avita Medical Inc
|
5.57 | 155.44M | 50.14M | -35.38M | -39.46M | -1.40 |
|
ABT
Abbott Laboratories
|
124.81 | 229.71B | 43.11B | 13.98B | 6.66B | 7.98 |
|
BSX
Boston Scientific Corp
|
103.62 | 154.35B | 17.55B | 2.03B | 2.72B | 1.37 |
|
SYK
Stryker Corp
|
393.57 | 149.60B | 23.22B | 2.86B | 3.58B | 7.40 |
|
MDT
Medtronic Plc
|
91.38 | 114.97B | 33.54B | 4.66B | 5.19B | 3.62 |
|
EW
Edwards Lifesciences Corp
|
76.23 | 45.92B | 5.54B | 4.18B | 623.10M | 7.00 |
Avita Medical Inc Stock (RCEL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-24-24 | Initiated | D. Boral Capital | Buy |
| Apr-11-24 | Downgrade | BTIG Research | Buy → Neutral |
| Jun-27-23 | Initiated | Cantor Fitzgerald | Overweight |
| Mar-02-21 | Initiated | Piper Sandler | Overweight |
| Aug-27-20 | Initiated | BofA Securities | Buy |
| Apr-21-20 | Initiated | Oppenheimer | Outperform |
| Mar-03-20 | Initiated | BTIG Research | Buy |
View All
Avita Medical Inc Stock (RCEL) Latest News
Is AVITA Medical Inc. a good long term investmentMassive profits - Autocar Professional
What analysts say about AVITA Medical Inc. stockFastest return on investment - PrintWeekIndia
What drives AVITA Medical Inc. stock priceBreakthrough capital growth - jammulinksnews.com
Will AVITA Medical Inc. stock benefit from AI tech trendsFree Expert-Led Investment Training - beatles.ru
AVITA Medical Inc. Stock Analysis and ForecastFree Stock Market Real-Time Monitoring - jammulinksnews.com
(RCEL) Trading Signals - news.stocktradersdaily.com
why avita medical inc. stock attracts strong analyst attentionPredictable Return Stock Picks - Newser
What makes AVITA Medical Inc. stock price move sharplyFree Real-Time Stock Data - Newser
Why AVITA Medical Inc. stock attracts strong analyst attentionProfessional Stock Screener - Newser
How AVITA Medical Inc. stock performs during market volatilityTop ROI Selections - Newser
When Can We Expect A Profit From AVITA Medical, Inc. (NASDAQ:RCEL)? - simplywall.st
Wealth Enhancement Advisory Services LLC Buys 2,564 Shares of Avita Medical Inc. (NASDAQ:RCEL) - Defense World
Ask the analyst: Can ASX growth story turn a profit before it’s too late? - Morningstar
Healthcare Stocks to Watch: Catalyst Pharmaceuticals, AVITA Medical, and Moleculin Biotech. - AInvest
AVITA Medical's High-Stakes Gamble: Can Break-Even Ambitions Outweigh the Debt? - AInvest
(RCEL) Trading Report - news.stocktradersdaily.com
Translational Regenerative Medicine Market Is Booming So - openPR.com
Cantor Fitzgerald Predicts AVITA Medical FY2026 Earnings - MarketBeat
AVITA Medical (RCEL) Receives Continued 'Buy' Rating from D. Bor - GuruFocus
Millennium Management LLC Makes New $426,000 Investment in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Avita Medical Says Data Show Recell Reduced Length of Hospital Stay for Burn Patients - MarketScreener
AVITA Medical Highlights Largest Real-World Analysis Demonstrati - GuruFocus
AVITA Medical (RCEL) Reports Significant Benefits of RECELL Technology in Burn Treatment | RCEL Stock News - GuruFocus
AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL | RCEL Stock News - GuruFocus
AVITA Medical Highlights Largest Real-World Analysis Demonstrating Reduced Hospital Stay with RECELL - The Manila Times
New Data: Revolutionary RECELL Treatment Cuts Hospital Stays by 35%, Saves Hospitals $300M in Burn Care - Stock Titan
Cantor Fitzgerald maintains Avita Medical at Overweight, $19 target By Investing.com - Investing.com Canada
AVITA Medical's (RCEL) Buy Rating Reaffirmed at D. Boral Capital - MarketBeat
AVITA Medical (NASDAQ:RCEL) Given “Buy” Rating at D. Boral Capital - Defense World
AVITA Medical, Inc. (NASDAQ:RCEL) Short Interest Up 23.9% in May - MarketBeat
RCEL: AVITA Medical Maintains Buy Rating with $19 Price Target | RCEL Stock News - GuruFocus
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™ - The Manila Times
Avita Medical (RCEL) Unveils Promising Results for Cohealyx in Wound Treatment | RCEL Stock News - GuruFocus
AVITA Medical’s Cohealyx shows promise in wound care - Investing.com
AVITA Medical Announces First Clinical Publication Demonstrating Accelerated Autograft Readiness with Cohealyx™ | RCEL Stock News - GuruFocus
AVITA Medical’s Cohealyx shows promise in wound care By Investing.com - Investing.com UK
Breakthrough: New Clinical Data Shows AVITA's Wound Treatment Heals 4x Faster Than Standard Care - Stock Titan
BNP Paribas Financial Markets Takes Position in AVITA Medical, Inc. (NASDAQ:RCEL) - Defense World
Avita Medical Stockholders Approve Key Amendments and Elections - TipRanks
Transcript : AVITA Medical, Inc.Shareholder/Analyst Call - MarketScreener
(RCEL) Investment Report - news.stocktradersdaily.com
AVITA Medical, Inc. (NASDAQ:RCEL) Shares Purchased by Ameriprise Financial Inc. - Defense World
AVITA Medical’s RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards - Yahoo Finance
AVITA Medical's RECELL Platform Recognized for Surgical Innovation in 2025 MedTech Breakthrough Awards | RCEL Stock News - GuruFocus
No normal is the new normal - The Globe and Mail
Revolutionary Wound Care Tech RECELL Crowned Best Surgical Innovation: How 30,000 Patients Benefited - Stock Titan
Avita Medical Inc Stock (RCEL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Avita Medical Inc Stock (RCEL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| McNamara Robert | Director |
Feb 20 '25 |
Buy |
10.09 |
10,000 |
100,900 |
45,749 |
| O'Toole David D | CFO |
Feb 20 '25 |
Buy |
9.90 |
1,000 |
9,900 |
25,734 |
| O'Toole David D | CFO |
Feb 19 '25 |
Buy |
10.25 |
1,000 |
10,250 |
24,734 |
| Crowe Suzanne | Director |
Dec 09 '24 |
Buy |
13.15 |
486 |
6,391 |
36,912 |
| O'Toole David D | CFO |
Dec 05 '24 |
Buy |
12.46 |
975 |
12,152 |
23,734 |
0.66%
0.50%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):